| Category | Antibody |
| Concentration | pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form | Antigen affinity purified |
| Conjugation | Unconjugated |
| Clone | Polyclonal antibody |
| Recognised antigen | REL |
| Host animal | Goat (Capra aegagrus hircus) |
| Clonality | Polyclonal (goat origin) |
| Species reactivity | Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications | ELISA (peptide), WB |
| Recommended dilutions | 5-2ug/ml, ELISA (peptide) LOD: 1:16000, Western blot: 0 |
| Notes | Optimal dilution of the REL antibody should be determined by the researcher |
| Intented use | This REL antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID # | 5966 |
| Purity | Antigen affinity |
| Description | Additional name(s) for this target protein: V-rel reticuloendotheliosis viral oncogene |
| Immunogen | Amino acids NDLNASNACIYN were used as the immunogen for this REL antibody |
| Storage | Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the REL antibody at -20 deg |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target | REL |
| Short name | REL Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | v-rel reticuloendotheliosis viral oncogene homolog (avian) (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | C-Rel, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0007249 and I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043123 and positive regulation of I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045084 and positive regulation of interleukin-12 biosynthetic process and biological process this GO :0045087 and innate immune response and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :1901215 and negative regulation of neuron death and biological process, REL and IDBG-53133 and ENSG00000162924 and 5966, REL and IDBG-634277 and ENSBTAG00000015386 and 509135, Rel and IDBG-155648 and ENSMUSG00000020275 and 19696, nuclei, sequence-specific DNA binding, this GO :0000980 and RNA polymerase II distal enhancer sequence-specific DNA binding and molecular function this GO :0001205 and RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and molecular function this GO :0001816 and cytokine production and biological process this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005667 and transcription factor complex and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0000980: RNA polymerase II distal enhancer sequence-specific DNA binding, this GO :0000980: RNA polymerase II distal enhancer sequence-specific DNA binding and also this GO :0001205: RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and also this GO :0003700: sequence-specific DNA binding transcription factor activity and also this GO :0005515: protein binding and also this GO :0043565: sequence-specific DNA binding, this GO :0001205: RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, this GO :0003700: sequence-specific DNA binding transcription factor activity, this GO :0005515: protein binding, this GO :0043565: sequence-specific DNA binding, v-rel reticuloendotheliosis viral oncogene homolog (avian) |
| Identity | 9954 |
| Gene | REL |
| Long gene name | NF-kB subunit , REL proto-oncogene |
| Synonyms gene name | v-rel avian reticuloendotheliosis viral oncogene homolog |
| Synonyms | I-Rel c-Rel |
| Locus | 2p16, 1 |
| Discovery year | 2001-06-22 |
| GenBank acession | M11595 |
| Entrez gene record | 5966 |
| Pubmed identfication | 1577270 |
| RefSeq identity | NM_002908 |
| Classification | NF-kappa B complex subunits |
| Havana BLAST/BLAT | OTTHUMG00000129418 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue